Keep up with all the latest news about how TEDCO is helping grow the Maryland entrepreneur funding sector through investments, network of industry professionals, and educational resources.
News & Events
TEDCO in the News
James Buck, CEO of MEDCURA
Jim Buck, President, CEO & Director, leveraging 30 years of experience successfully developing and commercializing innovative medical technologies. While holding a Board Director position at Medcura since 2018, Jim also served as the President and CEO of cancer imaging innovator ClearCut Medical
LEARN MORE
Money Moves: Astek Diagnostics raised $2M for a medical device launch
Baltimore’s biotech industry is thriving, and it’s not the only one experiencing a winning streak. Plus, JHU launches its inaugural President's Venture Fellowship, Squadra Ventures invests in a Texas firmware company and Rampart Communications seeks $20 million.
LEARN MORE
Maryland startup Keep Company raises $800K to help its clients slow parent, caregiver attrition
It costs a law firm $650,000 every time an attorney leaves due to burn out, the founders said. They've built a system to prevent that.
LEARN MORE
Bethesda startup Keep Company raises $800K to help its clients slow parent, caregiver attrition.
Bethesda-based employee wellness and retention startup Keep Company will use $800,000 from a recently announced pre-seed round to further its product development and gain a foothold in new industries.
LEARN MORE
Press Releases
TEDCO Announces SSBCI Investment into Givhero
Maryland small business helping employers to support their employees’ health COLUMBIA, Md. (May 18
LEARN MORE
TEDCO Invests in Routespring
Maryland small business creating travel opportunities for other businesses COLUMBIA, Md. (May 17
LEARN MORE
Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Cures
Commission also issues Request for Applications for Four Funding Programs for July 13, 2023
LEARN MORE
TEDCO Announces Investment into Rise Therapeutics
Biotech company receives follow-on funding to accelerate ongoing clinical development efforts
LEARN MORE